• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗北部肾移植后恶性肿瘤的发病率和危险因素:20 年经验。

Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.

机构信息

Urology Research Center, School of Medicine, Razi hospital, Guilan University of Medical Sciences, Rasht, Iran.

出版信息

Iran J Kidney Dis. 2020 Dec;14(6):439-447.

PMID:33277447
Abstract

INTRODUCTION

The main causes of death in kidney transplant recipients are cardiovascular diseases and malignancy. This study aimed to determine the types of post-transplant malignancy, incidence, and related factors in renal transplant recipients referred to Razi Hospital in Rasht, Iran.

METHODS

This retrospective cross-sectional study was conducted on 549 kidney transplant recipients between 1998 and 2018. Patient-, transplant-, and medication-related factors and pathology reports were recorded in the check list. Chi-square, T-test and Logistic Regression were used to investigate the effect of variables. Malignancy-person-year incidence rate was calculated using survival tables and Kaplan-Mayer analysis.

RESULTS

43 (7.8%) recipients had malignancies. The most common site of malignancy was the skin (53.5%). Non-Melanoma Skin Cancer (NMSC) was the most common cancer (32.6%) followed by Kaposi sarcoma (20.9%). The standardized incidence ratio (SIR) of post-transplant malignancies in renal transplant recipients was 26.9 times the malignancies in Guilan province and 21.7 times the malignancies in Iran. Cox proportional hazard models identified older age at the time of transplantation and history of azathioprine consumption seems to be associated with risk for post-transplant malignancy.

CONCLUSION

The most common malignancies in these people were non-melanoma skin cancer, Kaposi sarcoma and then GI malignancies. According to the information obtained in this study, regular periodic examinations of kidney transplant recipients for early detection of malignancy is important.

摘要

简介

肾移植受者的主要死亡原因是心血管疾病和恶性肿瘤。本研究旨在确定拉什特拉齐医院肾移植受者的移植后恶性肿瘤类型、发病率及相关因素。

方法

本回顾性横断面研究于 1998 年至 2018 年期间对 549 名肾移植受者进行。在检查表中记录了患者、移植和药物相关因素以及病理报告。采用卡方检验、T 检验和逻辑回归分析变量的影响。使用生存表和 Kaplan-Meier 分析计算恶性肿瘤的人年发病率。

结果

43 名(7.8%)受者患有恶性肿瘤。最常见的恶性肿瘤部位是皮肤(53.5%)。非黑素瘤皮肤癌(NMSC)是最常见的癌症(32.6%),其次是卡波西肉瘤(20.9%)。肾移植受者的移植后恶性肿瘤的标准化发病比(SIR)是古兰省恶性肿瘤的 26.9 倍,是伊朗恶性肿瘤的 21.7 倍。Cox 比例风险模型确定,移植时年龄较大和使用硫唑嘌呤的病史与移植后恶性肿瘤的风险相关。

结论

这些患者中最常见的恶性肿瘤是非黑素瘤皮肤癌、卡波西肉瘤,然后是胃肠道恶性肿瘤。根据本研究获得的信息,定期对肾移植受者进行检查以早期发现恶性肿瘤非常重要。

相似文献

1
Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.伊朗北部肾移植后恶性肿瘤的发病率和危险因素:20 年经验。
Iran J Kidney Dis. 2020 Dec;14(6):439-447.
2
Skin cancer after renal transplantation: Results of a multicenter study in Iran.肾移植后皮肤癌:伊朗一项多中心研究的结果。
Ann Transplant. 2010 Jul-Sep;15(3):44-50.
3
Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.肾移植受者移植后恶性肿瘤的不同发病时间:单中心经验
Transpl Int. 2009 Jun;22(6):644-53. doi: 10.1111/j.1432-2277.2009.00846.x. Epub 2009 Feb 10.
4
Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.葡萄牙肾移植受者的非黑色素瘤皮肤癌——发病率及危险因素
An Bras Dermatol. 2016 Jul-Aug;91(4):455-62. doi: 10.1590/abd1806-4841.20164891.
5
The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.mTOR 抑制剂免疫抑制方案转换对肝肾移植受者长期非黑色素瘤皮肤癌发病率和肾功能的影响。
Ren Fail. 2020 Nov;42(1):607-612. doi: 10.1080/0886022X.2020.1785499.
6
Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.单中心674例实体器官移植受者的移植后恶性肿瘤发病率。
Clin Transplant. 1996 Jun;10(3):248-55.
7
Special malignancy pattern in Chinese renal transplantation recipients: a single center experience and literature review.中国肾移植受者的特殊恶性肿瘤模式:单中心经验及文献综述
Asian Pac J Cancer Prev. 2011;12(12):3347-51.
8
Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience.肾移植受者中卡波西肉瘤的发病率及管理:希腊的经验
Transplant Proc. 2014 Nov;46(9):3199-202. doi: 10.1016/j.transproceed.2014.09.165.
9
Malignancy following renal transplantation.肾移植后的恶性肿瘤
Zhonghua Yi Xue Za Zhi (Taipei). 1998 May;61(5):281-8.
10
De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.台湾地区心、肾、肝移植后新发恶性肿瘤:一项全国性研究。
Exp Clin Transplant. 2020 Apr;18(2):224-233. doi: 10.6002/ect.2019.0210. Epub 2020 Mar 4.